Human papillomavirus self‐testing among unscreened and under‐screened Māori, Pasifika and Asian women in Aotearoa New Zealand: A preference survey among responders and interviews with clinical‐trial nonresponders. (26th September 2022)

• Record Type: Journal Article
• Authors: Sherman, Susan M.; Brewer, Naomi; Bartholomew, Karen; Bromhead, Collette; Crengle, Sue; Cunningham, Chris; Douwes, Jeroen; Foliaki, Sunia; Grant, Jane; Maxwell, Anna; McPherson, Georgina; Scott, Nina; Wihongi, Helen; Potter, John D.
• Is Part Of: Health expectations. Volume 25:Number 6(2022)
• Page Start: 2914
• Page End: 2923
• Publication Date: 2022-09-26
• Subjects: acceptability -- Asian women -- HPV -- Māori women -- Pasifika women -- self‐sample -- self‐test; Medical policy -- Periodicals; Public health -- Periodicals; Health planning -- Periodicals; 362.105
• DOI: 10.1111/hex.13599
• Languages: English
• ISSNs: 1369-6513

Abstract

Abstract: Introduction: Māori, Pasifika and Asian women are less likely to attend cervical screening and Māori and Pasifika women are more likely to be diagnosed with later‐stage cervical cancer than other women in Aotearoa New Zealand. This study—with under‐screened women taking part in a randomized‐controlled trial comparing self‐testing and standard screening—explored the acceptability of a human papillomavirus (HPV) self‐test kit and the preferred method for receiving it. Methods: Māori, Pasifika and Asian women ( N = 376) completed a cross‐sectional postal questionnaire. Twenty‐six women who had not accepted the trial invitation were interviewed to understand their reasons for nonparticipation. Results: Most women found the self‐test kit easy and convenient to use and reported that they did not find it painful, uncomfortable or embarrassing. This was reflected in the preference for a self‐test over a future smear test on the same grounds. Most women preferred to receive the kit by mail and take the test themselves, rather than having it done by a doctor or nurse. There was a range of preferences relating to how to return the kit. Phone calls with nonresponders revealed that, although most had received the test kit, the reasons for not choosing to be involved included not wanting to, being too busy or forgetting. Conclusion: HPV self‐testing was acceptable for Māori, Pasifika and Asian women in Aotearoa New Zealand. HPV self‐testing has considerable potential to reduce the inequities in the current screening programme and should be made available with appropriate delivery options as soon as possible. Patient or Public Contribution: This study explored the acceptability of HPV self‐testing and their preferences for engaging with it among Māori, Pasifika and Asian women. Thus, women from these underserved communities were the participants and focus of this study.